Abstract
Autism spectrum disorder (ASD) is often complicated by psychiatric and medical comorbidities such as intellectual disability, epilepsy, anxiety, mood disorders, sleep issues, and gastrointestinal problems. Behavioral issues including self-injury and aggression are common and cause need for hospitalization and escalating pharmacotherapeutic intervention. The case described below is of an adolescent whose autism and comorbid intellectual disability were complicated by dangerous self-injury. The optimal management included careful analysis of behavioral reinforcers and institution of both a closely monitored and dynamically modified behavioral plan integrated into his home, school, and therapeutic environment. It also included judicious use of a range of psychotropic medications to ensure safety and maximize his capacity to build skills, utilize available therapies, and flourish in the setting of his complex constellation of challenges.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Duerden EG, et al. Self-injurious behaviours are associated with alterations in the somatosensory system in children with autism spectrum disorder. Brain Struct Funct. 2014;219(4):1251–61. ISSN 1863-2661. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/23644587 >.
Wolff JJ, et al. Repetitive and self-injurious behaviors: associations with caudate volume in autism and fragile X syndrome. J Neurodev Disord. 2013;5(1):12. ISSN 1866-1947. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/23639144 >.
Deon LL, et al. Pallidal deep-brain stimulation associated with complete remission of self-injurious behaviors in a patient with Lesch-Nyhan syndrome: a case report. J Child Neurol. 2012;27(1):117–20. ISSN 1708-8283. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/21940691 >.
Taira T, Kobayashi T, Hori T. Disappearance of self-mutilating behavior in a patient with lesch-nyhan syndrome after bilateral chronic stimulation of the globus pallidus internus. Case report. J Neurosurg. 2003;98(2):414–6. ISSN 0022-3085. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/12593632 >.
Sturm V, et al. DBS in the basolateral amygdala improves symptoms of autism and related self-injurious behavior: a case report and hypothesis on the pathogenesis of the disorder. Front Hum Neurosci. 2012;6:341. ISSN 1662-5161. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/23346052 >.
Minshawi NF, et al. Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach. J Autism Dev Disord. 2015;5(6):1541–68. ISSN 1573-3432. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/25395094 >.
Richardson C. Self-harm: understanding the causes and treatment options. Nurs Times. 2004;100(15):24–5. ISSN 0954-7762. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/15119257 >.
Richardson JS, Zaleski WA. Endogenous opiates and self-mutilation. Am J Psychiatry. 1986;143(7):938–9. ISSN 0002-953X. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/3717448 >.
Sandman CA, et al. The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Dev Psychobiol. 2008;50(7):680–9. ISSN 1098-2302. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/18688808 >.
Baghdadli A, et al. Risk factors for self-injurious behaviours among 222 young children with autistic disorders. J Intellect Disabil Res. 2003;47(Pt 8):622–7. ISSN 0964-2633. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/14641810 >.
Handen BL, et al. Risk factors for self-injurious behavior in an inpatient psychiatric sample of children with autism spectrum disorder: a naturalistic observation study. J Autism Dev Disord. 2018. ISSN 1573-3432. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/29368233 >.
Arnold LE, et al. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. J Am Acad Child Adolesc Psychiatry. 2003;42(12):1443–50. ISSN 0890-8567. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/14627879 >.
Davis NO, Carter AS. Parenting stress in mothers and fathers of toddlers with autism spectrum disorders: associations with child characteristics. J Autism Dev Disord. 2008;38(7):1278–91. ISSN 0162-3257. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/18240012 >.
Skinner BF. The behavior of organisms; an experimental analysis. New York/London: D. Appleton-Century Company; 1938. p. ix. 457 p.
Cooper JO, Heron TE, Heward WL. Applied behavior analysis. 2nd ed. Upper Saddle River: Pearson/Merrill-Prentice Hall; 2007. xxvii, 770 p. ISBN 01314211319780131421134.
McCracken JT, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314–21. ISSN 1533-4406. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/12151468 >.
McDougle CJ, et al. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry. 1998;55(7):633–41. ISSN 0003-990X. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/9672054 >.
Owen R, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124(6):1533–40. ISSN 1098-4275. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/19948625 >.
Shea S, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004;114(5):e634–41. ISSN 1098-4275. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/15492353 >.
Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. J Child Adolesc Psychopharmacol. 2008;18(2):157–78. ISSN 1044-5463. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/18439113 >.
Patel NC, et al. Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2005;44(6):548–56. ISSN 0890-8567. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/15908837 >.
Cohen D, et al. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry. 2000;157(3):460–2. ISSN 0002-953X. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/10698827 >.
Hammock R, Levine WR, Schroeder SR. Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation. J Autism Dev Disord. 2001;31(1):109–13. ISSN 0162-3257. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/11439749 >.
Janowsky DS, Barnhill LJ, Davis JM. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial. J Clin Psychiatry. 2003;64(10):1258–65. ISSN 0160-6689. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/14658977 >.
McDougle CJ, Kem DL, Posey DJ. Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry. 2002;41(8):921–7. ISSN 0890-8567. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/12164181 >.
Aman MG, et al. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry. 2002;159(8):1337–46. ISSN 0002-953X. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/12153826 >.
Snyder R, et al. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry. 2002;41(9):1026–36. ISSN 0890-8567. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/12218423 >.
Malone RP, et al. Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. J Am Acad Child Adolesc Psychiatry. 2001;40(8):887–94. ISSN 0890-8567. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/11501687 >.
Jaselskis CA, et al. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol. 1992;12(5):322–7. ISSN 0271-0749. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/1479049 >.
Sagar-Ouriaghli I, Lievesley K, Santosh PJ. Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders. J Psychopharmacol. 2018;269881118756245. ISSN 1461–7285. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/29484909 >.
Accordino RE, et al. Psychopharmacological interventions in autism spectrum disorder. Expert Opin Pharmacother. 2016;17(7):937–52. ISSN 1744-7666. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/26891879 >.
Bloch MR, et al. Fluoxetine in pathologic skin-picking: open-label and double-blind results. Psychosomatics. 2001;42(4):314–9. ISSN 0033–3182. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/11496020 >.
Hellings JA, Warnock JK. Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacol Bull. 1994;30(2):245–50. ISSN 0048-5764. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/7831463 >.
Sovner R, et al. Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation. J Intellect Disabil Res. 1993;37(Pt 3):301–11. ISSN 0964-2633. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/8334322 >.
Stout RJ. Fluoxetine for the treatment of compulsive facial picking. Am J Psychiatry. 1990;147(3):370. ISSN 0002-953X. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/2309961 >.
Davanzo PA, et al. Paroxetine treatment of aggression and self-injury in persons with mental retardation. Am J Ment Retard. 1998;102(5):427–37. ISSN 0895-8017. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/9544340 >.
McDougle CJ, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 1996;53(11):1001–8. ISSN 0003-990X. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/8911223 >.
Garber HJ, et al. Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities. J Am Acad Child Adolesc Psychiatry. 1992;31(6):1157–60. ISSN 0890-8567. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/1429420 >.
Lewis MH, et al. Clomipramine treatment for self-injurious behavior of individuals with mental retardation: a double-blind comparison with placebo. Am J Ment Retard. 1996;100(6):654–65. ISSN 0895-8017. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/8735578 >.
Buitelaar JK, Van Der Gaag RJ, Van Der Hoeven J. Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. J Clin Psychiatry. 1998;59(2):56–9. ISSN 0160-6689. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/9501886 >.
Chugani DC, et al. Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: a randomized trial. J Pediatr. 2016;170:45–53.e1-4. ISSN 1097-6833. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/26746121 >.
Hellings JA, et al. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2005;15(4):682–92. ISSN 1044-5463. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/16190799 >.
Belsito KM, et al. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord. 2001;31(2):175–81. ISSN 0162-3257. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/11450816 >.
Serret S, et al. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports. BMC Psychiatry. 2015;15:107. ISSN 1471-244X. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/25947967 >.
Siegel M, et al. Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2014;24(7):399–402. ISSN 1557-8992. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/25093602 >.
Roy A, et al. Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review. J Intellect Disabil Res. 2015;59(4):293–306. ISSN 1365-2788. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/24589346 >.
Symons FJ, Thompson A, Rodriguez MC. Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis. Ment Retard Dev Disabil Res Rev. 2004;10(3):193–200. ISSN 1080-4013. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/15611982 >.
Ghaleiha A, et al. Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. Int J Neuropsychopharmacol. 2013;16(4):783–9. ISSN 1469-5111. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/22999292 >.
Dean OM, Gray KM, Villagonzalo KA, et al. A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder. Aust N Z J Psychiatry. 2017;51(3):241–9.
Hardan AY, et al. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry. 2012;71(11):956–61. ISSN 1873-2402. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/22342106 >.
Wink LK, Adams R, Wang Z, et al. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Mol Autism. 2016;7:26.
Erickson CA, et al. STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord. 2014;44(4):958–64. ISSN 1573-3432. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/24272415 >.
Consoli A, et al. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res. 2012;37(1–3):151–8. ISSN 1573-2509. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/22401837 >.
Dhossche DM, Wachtel LE. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol. 2010;43(5):307–15. ISSN 1873-5150. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/20933172 >.
Wachtel LE, et al. ECT for self-injury in an autistic boy. Eur Child Adolesc Psychiatry. 2009;18(7):458–63. ISSN 1435-165X. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/19198918 >.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Almai, A.M., Hauptman, A.J. (2019). Growing Up with Autism: Incorporating Behavioral Management and Medication to Manage Self-Injurious Behavior. In: Hauptman, A., Salpekar, J. (eds) Pediatric Neuropsychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-94998-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-94998-7_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-94997-0
Online ISBN: 978-3-319-94998-7
eBook Packages: MedicineMedicine (R0)